Comprehensive Analysis On Indian Ophthalmology Therapeutics Market 2023 With Future Trend, Market Size, Business Growth, Top Key players, CAGR

Report Overview

Indian Ophthalmology Therapeutics Market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX% during the forecast period (2019-2028)

Ophthalmology-based diseases in India are increasing. It is reported to cross 5 million cataract surgeries are performed in India. The majority of these procedures involve intraocular lens implantation. The projection is based on the current incidence rates of 45% in Indian urban population. There is a significant and growing burden of moderate visual impairment in India. Based upon increasing burden of eye diseases and moderate growth in technological advancements, the market is up to register a CAGR of 7.3%. The diagnostic equipment market is the second largest ophthalmic market in India and is growing with $257 million in 2022.

Market Driving and Restraining Factors

Driving Factors

An increasing number of people suffering from diabetes and glaucoma, Elderly population, urban residence, low socio-economic affluence, increasing incidence of vision impairment, high innovation, and heavy funding in the development of combination therapies are the major factors driving the growth of this market.

Restraining Factors

Stringent regulatory framework and unclear reimbursement policies are also acting as hurdles for Industry growth. Lack of awareness about various diseases associated with ophthalmology is also a major restraint hindering the Industry growth. Adverse side-effects and long gestation periods in the development of new drugs hamper market growth.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/139696/

Major Players

The Indian ophthalmic therapeutics market is rapidly growing, and it consists of a number of major players. Market Scope estimates that would be more than 100 companies competing in India's ophthalmic market. The major players are Alcon, Allergan, Johnson & Johnson Vision, Novartis, Carl Zeiss Meditec, Bausch + Lomb, Sun, Appasamy, and Santen make up more than two-thirds of manufacturer revenues, leaving the smaller market players competing for the remaining 32 percent of the ophthalmic market opportunity in India. In November 2017, Zeiss introduced the cloud-based cataract surgery planning platform, Veracity Surgical, and announced the integration with leading EMRs.

The Indian Ophthalmology Therapeutics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Indian Ophthalmology Therapeutics market. This report explores all the key factors affecting the growth of the global Indian Ophthalmology Therapeutics market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

To Know More About COVID-19 Impact On Indian Ophthalmology Therapeutics Market @ https://www.prudentmarkets.com/sample-request/139696/

Market Segmentation

By Route of Administration:

By way of administration, market is segmented into Topical, Locular Ocular, Subconjunctival, Intravitreal, Retrobulbar, Intracameral, and Systemic. Revenues from cataract surgery in India are expected to generate more than a quarter of the total ophthalmic market revenues in the country. The topical route of administration segment dominated the market for ophthalmic drugs and accounted for the largest revenue share 62.2% in 2020 and is estimated to continue the dominance over the forecast period. The presence of strong pipeline products and increasing sales volume of ophthalmic drugs for retinal disorders is expected to be one of the major factors driving the market over the forecast period.

By Dosage Form:

Indian ophthalmology therapeutics market can also be segmented as Gels, Eye solutions, Capsules & Tablets, Eye drops, Ointments. The eye drops segment dominated the ophthalmic drugs market and accounted for the largest revenue share of 34.6% in 2020. The segment was driven by the ease of usage and high patient compliance. In addition, the development of eye drops for the treatment of rare eye diseases with low prevalence yet has a devastating impact on patients is expected to drive the market.

By Indication:

Based on Indication, Indian Ophthalmology therapeutic market is segmented into Glaucoma, Dry eye syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age- related macular degeneration, Macular Edema, Allergic Conjunctivitis. Glaucoma is the largest indication segment followed by Age-Related Macular Degeneration.

By Drug Class:

Based on drug class, Indian Ophthalmology therapeutic market is segmented into Antiallergy, Anti-VEGF Agents, Anti-inflammatory, Nonsteroidal drugs, Antiglaucoma.

Major Players

The Indian ophthalmic therapeutics market is rapidly growing, and it consists of a number of major players. Market Scope estimates that would be more than 100 companies competing in India's ophthalmic market. The major players are Alcon, Allergan, Johnson & Johnson Vision, Novartis, Carl Zeiss Meditec, Bausch + Lomb, Sun, Appasamy, and Santen make up more than two-thirds of manufacturer revenues, leaving the smaller market players competing for the remaining 32 percent of the ophthalmic market opportunity in India. In November 2017, Zeiss introduced the cloud-based cataract surgery planning platform, Veracity Surgical, and announced the integration with leading EMRs.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/139696/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Indian Ophthalmology Therapeutics Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Indian Ophthalmology Therapeutics Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Indian Ophthalmology Therapeutics market
Chapter 2: Exclusive Summary - the basic information of the Indian Ophthalmology Therapeutics Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Indian Ophthalmology Therapeutics
Chapter 4: Presenting the Indian Ophthalmology Therapeutics Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Indian Ophthalmology Therapeutics market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/139696/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Indian Ophthalmology Therapeutics Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.